WASHINGTON – Allopurinol has no effect on heart failure, according to results from the multicenter, double-blind EXACT-HF study.
"In heart failure patients with reduced ejection fraction and...
WASHINGTON – Long-term dual-antiplatelet therapy may provide a mortality benefit over aspirin alone in patients with symptomatic peripheral artery disease.
In an observational study of 629 patients...
WASHINGTON – A third more Americans were hospitalized for ischemic stroke in 2010 than 7 years before, and the incidence of stroke associated with atrial fibrillation grew even more sharply, up by...
LONDON – Simvastatin improves short-term survival after variceal bleeding in patients with cirrhosis, results of a phase III, randomized, double blind study have shown.
At 2 years’ follow-up in the...
CHICAGO – The Food and Drug Administration’s letter rating scale is "unreliable" when it comes to prescribing antidepressants for pregnant women, according to Dr. Marlene P. Freeman,...
WASHINGTON – Marital status plays an underappreciated role in heart failure prognosis.
Indeed, having a life partner was independently associated with a 12% reduction in the risk of all-cause...
Hospitalists who care for dementia patients near the end of life are much less likely to introduce a feeding tube than other physicians who follow such patients.
Compared with nonhospital...
WASHINGTON – The controversial cardiovascular risk estimator introduced in the current American College of Cardiology/American Heart Association risk-assessment guidelines demonstrated "moderate...
The approval of cardiac resynchronization pacemakers and defibrillators manufactured by Medtronic has been expanded to include patients with atrioventricular block and less severe heart failure, the...
WASHINGTON – Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive or submassive pulmonary embolism significantly improves right ventricular function, reduces pulmonary...